CompletedNot Applicable

MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla

France35 participantsStarted 2018-02-23

Plain-language summary

Our objective is to allow positive MRI diagnosis of vestibular neuritis by highlighting contrast enhancement of the vestibular nerve on the pathological side of the FLAIR sequence acquired 1h after intravenous gadolinium injection in patients with typical vestibular neuritis. At present, the diagnosis is based on a combination clinical examination / video-head impulse test, and no imaging examination allows the diagnosis to be positive.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-80 years * Presence of a typical unilateral vestibular neuritis during the ENT examination with videonystagmography * Subject having his agreement for the use of his medical data for research purposes. Exclusion Criteria: * Special clinical forms of the disease: doubtful or atypical forms, especially the presence of deafness * Treatments and related interfering diseases, antecedents: antecedents of neuritis for controls, presence of vertigo, bilateral involvement * Impossibility to give the subject information enlightened (subject in emergency situation, difficulties of understanding the subject, ...) * Subject under the protection of justice * Subject under guardianship or curatorship

What they're measuring

Diagnosis of vestibular neuritis

Timeframe: one hour after intravenous gadolinium injection

Trial details

NCT IDNCT03452410

SponsorUniversity Hospital, Strasbourg, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-02-23

View on ClinicalTrials.gov More Vestibular Neuritis trials